Additionally, it does not detect non‐classical galactosaemia due to galactokinase, epimerase or mutarotase deficiency, which are secondary targets of NBS using a primary TGAL approach. This evidence concerns the gene GALK1 and hyperinsulinemic hypoglycemia, familial, 4.